
05/05/2025
A surge in emergency room visits tied to popular weight-loss medications has raised new concerns about their side effects. Between 2022 and 2023, nearly 25,000 hospital visits were linked to semaglutide, the active ingredient in Ozempic and Wegovy, according to new health surveillance data. The majority of these cases occurred in 2023, underscoring the need for increased awareness around the risks of these widely used medications....
A surge in emergency room visits tied to popular weight-loss medications has raised new concerns about their side effects. Between 2022 and 2023, nearly...